The technical documentation required for Class I medical device registration with China's National Medical Products Administration (NMPA) is essential to demonstrate the safety, efficacy, and quality of your device. Here are the key technical documentation requirements typically needed:

1. Device Description:

   • Detailed description of the device, including its intended use, indications, and specifications.
   • Schematic drawings or diagrams if applicable.

2. Manufacturing Process Details:

   • Information on how the device is manufactured, including materials used, production methods, and quality control measures.

3. Risk Assessment Documentation:

   • Evaluation of potential risks associated with the device and mitigation measures implemented to ensure safety. This includes identifying and analyzing risks related to device design, materials, manufacturing processes, and intended use scenarios.

4. Testing Reports:

   • Comprehensive testing reports demonstrating compliance with applicable standards and regulations. The specific tests required may include:
     • Biocompatibility testing (e.g., ISO 10993 series)
     • Electrical safety testing (e.g., IEC 60601-1)
     • Performance testing relevant to the device’s intended use
     • Sterility testing (if applicable)
     • Shelf-life testing (if applicable)
   • Ensure that all testing is conducted by accredited laboratories and that the reports are up-to-date and relevant to the current version of your device.

5. Instructions for Use (IFU):

   • Clear and comprehensive instructions for users on how to correctly use the device. This should include information on device setup, operation, maintenance, and troubleshooting, as well as any precautions or warnings.

6. Quality Management System (QMS) Documentation:

   • Evidence of compliance with a recognized quality management system standard, such as ISO 13485. This includes documentation of your QMS procedures related to design controls, production controls, quality assurance, and post-market surveillance.

7. Clinical Evaluation (if required):

   • Clinical data or literature demonstrating the safety and performance of the device, if a clinical evaluation is necessary based on regulatory requirements or device classification.

8. Labeling and Packaging Information:

   • Details of labeling and packaging materials, including label content, symbols used, and compliance with Chinese labeling requirements.

9. Declaration of Conformity:

   • Declaration that the device conforms to relevant Chinese standards and regulations, signed by a responsible individual within your organization.

10. Translation into Chinese:

    • Ensure that all technical documentation is translated into Chinese. This is typically required for submission to the NMPA.

Additional Considerations:

• Regulatory Updates: Stay informed about any changes or updates in Chinese regulatory requirements that may impact the technical documentation needed for your device.

• Comprehensive Documentation: Thoroughly compile all required documents into a well-organized and complete application package to facilitate the review process by the NMPA.

• Local Agent Support: Working closely with a qualified local agent in China can provide valuable guidance on meeting technical documentation requirements and navigating the regulatory landscape.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn